NL-OMON48328招募中不适用
PET/CT Robustness In Melanoma - PRIME
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 28 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. *18 years old
- •2. Histopathologically confirmed melanoma
- •3. Clinical stage IIIB/C/D, IV melanoma
- •4. Scheduled for a routine baseline [18F]-FDG PET/CT scan
- •5. Minimal one lesion with longest diameter * 20 mm
- •6. WHO performance status * 2
- •7. Ability to undergo the scan in supine position
- •8. Capacity to give informed consent
排除标准
- •1. Pregnant
- •2. Breast feeding
- •3. Claustrophobia
- •4. Confirmed diabetes mellitus I or II
- •5. Body weight >100 kg
- •6. Metal implants/prostheses, evaluated by study team
- •7. No systemic therapy (chemotherapy, immunotherapy, targeted therapy) 3
- •months prior to scan
研究者
相似试验
进行中（未招募）
不适用
PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing StudyNewly Diagnosed or Recurrent Metastatic Melanoma PatientsMalignant Brain TumorsNCT01266096Memorial Sloan Kettering Cancer Center10
已完成
不适用
PD-L1 PET imaging in patients with melanoma or NSCLC with brain metastasis and eligible for treatment with nivolumabNL-OMON46055niversitair Medisch Centrum Groningen15
尚未招募
Unknown
Role of PET CT evaluation in patients with carcinoma of breast having cN1 statusCTRI/2023/07/054982Dean, Kasturba Medical College, Manipal
进行中（未招募）
1 期
FAPI-PET imaging in solid tumorsCancerCTIS2024-514967-25-00Karolinska University Hospital410
尚未招募
不适用
tility of 11C-Methionine PET in assessing malignancy of tumorsBrain tumor, Head and neck cancer, lung cancer, soft tissue tumor, pancreas cancerJPRN-UMIN000020581Kyushu University Hospital, Department of Clinical Radiology150